Showing results (61-70 of 200) with videos related to

Sort By:
Pageof 20
Current Opinion in Immunology|June 28, 2011
Immune responses in the skin in old ageMilica Vukmanovic-Stejic, Malcolm H A Rustin, Janko Nikolich-Zugich, et al.
Human Immunology|April 17, 2010
Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subsetRichard P G Hayhoe, Sian M Henson, Arne N Akbar, et al.
Aging|January 29, 2019
CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with ageBojana Müller-Durovic, Jasmin Grählert, Oliver P Devine, et al.
Blood|July 8, 2010
Priming innate immune responses to infection by cyclooxygenase inhibition kills antibiotic-susceptible and -resistant bacteriaMelanie J Stables, Justine Newson, Samir S Ayoub, et al.
British Journal of Pharmacology|January 30, 2002
Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cellsJamie D Croxtall, Peter Th W van Hal, Qam Choudhury, et al.
Arthritis and Rheumatism|August 31, 2004
Reduced infiltration and increased apoptosis of leukocytes at sites of inflammation by systemic administration of a membrane-permeable IkappaBalpha repressorNathan M Blackwell, Phupinder Sembi, Justine S Newson, et al.
European Journal of Immunology|February 25, 2015
Blockade of PD-1 or p38 MAP kinase signaling enhances senescent human CD8(+) T-cell proliferation by distinct pathwaysSian M Henson, Richard Macaulay, Natalie E Riddell, et al.
Human Immunology|December 11, 2012
Differing HLA types influence inhibitory receptor signalling in CMV-specific CD8+ T cellsRichard Macaulay, Natalie E Riddell, Stephen J Griffiths, et al.
Nature Communications|May 21, 2024
Post-resolution macrophages shape long-term tissue immunity and integrity in a mouse model of pneumococcal pneumoniaKaren T Feehan, Hannah E Bridgewater, Jan Stenkiewicz-Witeska, et al.
Journal of Visualized Experiments : Jove|May 24, 2016
Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic InflammationJames N Fullerton, Elisabetta Segre, Roel P H De Maeyer, et al.
Pageof 20